Like most competition law regimes around the world, Malaysia’s Competition Act 2010 contains provisions prohibiting anti-competitive practices and abuses of dominance. However, it does not currently include the third “pillar” of competition law that is common to many other regimes, namely, cross sector merger control rules. Such rules enable competition authorities to review transactions and … Read more

We are delighted to share with you the latest update of our report on Foreign Investment: Rising Tides of Politics in Regulation. This edition has been fully updated to reflect the tabling of the National Security and Investment Bill before the UK Parliament, which seeks to introduce a new distinct regime and standalone powers for … Read more

We are delighted to share with you our newly updated report on Foreign Investment: Rising Tides of Politics in Regulation, which reflects a swathe of recent changes to Foreign Direct Investment (FDI) regimes around the world against the backdrop of the Covid-19 pandemic. FDI filings have become an increasingly important piece of the regulatory jigsaw … Read more

The Covid-19 health crisis raises substantial challenges for businesses and consumers and has had a significant impact on competition law affecting the consumer sector. While the particular implications will vary by jurisdiction, some common trends may be identified. One broader development is that competition authorities have recognised that certain forms of temporary cooperation between businesses, … Read more

The Indonesian Competition Commission (“KPPU”) has been scrutinizing several business sectors following the global economic slowdown as a result of the COVID-19 pandemic. These sectors are primarily healthcare services, medical equipment, and essential commodities (food). One currently booming sector under watch by KPPU is healthcare. On April 14, KPPU issued a press release (Press Release … Read more

On 9 April 2020, China’s State Administration for Market Regulation (SAMR) fined 3 pharmaceutical companies for abuse of dominance in the distribution of injectable calcium gluconate Active Pharmaceutical Ingredient (API). The three companies were found to be in breach of the PRC’s Anti-Monopoly Law (the AML) between August 2015 and December 2017, by selling at … Read more

The rapid spread of COVID-19 across the world, and notably Europe, in recent weeks is placing increasing strain on our economies, in addition to the tragic human impact. Several implications for competition law have already emerged, as indicated (non-exhaustively) below. Competition authorities are hot to respond to price gouging and exploitation allegations Numerous competition authorities … Read more

Our newly updated report on Foreign Investment: Rising Tides of Politics in Regulation is now available. Foreign Direct Investment (FDI) filings are an increasingly important piece of the regulatory jigsaw for cross-border M&A. Against a background of mounting protectionist rhetoric, countries traditionally open to investment (such as the US, UK and Australia) are moving towards … Read more